Testosterone Replacement Therapy for Patients with Chronic Pain and Low Testosterone

Indications and Diagnosis

The American College of Physicians recommends testosterone replacement therapy for men with confirmed low testosterone levels and corresponding symptoms, such as decreased libido, fatigue, and mood changes 1
Diagnosis requires low testosterone levels (<300 ng/dL) in at least two separate morning measurements and presence of symptoms/signs 1

The Endocrine Society recommends transdermal formulations, which provide stable testosterone levels and avoid fluctuations observed with intramuscular injections 1
Transdermal formulations restore testosterone levels to mid-normal physiological values (14-17.5 nmol/L) and have a lower risk of polycythemia (3-18%) compared to injections (up to 44%) 1
Intramuscular injections are a more economical option ($156.24 annually) compared to topical gels/creams ($2,135.32 annually) 1
The FDA specifically contraindicates the use of oral testosterone formulations for "age-related hypogonadism" not associated with structural or genetic etiologies 2

The use of opioids, such as Restiva, can cause secondary hypogonadism, making it essential to evaluate the cause of low testosterone levels 1
The patient's age (43 years) and use of opioid analgesics are crucial factors in choosing therapy 2, 3

Monitor testosterone levels 2-3 months after starting treatment and reevaluate symptoms within 12 months 1
Monitor PSA and prostate function, especially in men over 40 years old 4
Long-term studies show a low frequency of prostate cancer associated with testosterone replacement therapy (1.1% in prospective studies) 4
Monitor hematocrit to detect polycythemia, which is less common with transdermal formulations 1